GlobeNewswire 5/6/2020 Three-month interim report (Q1) 2020
GlobeNewswire 2/5/2020 ALK releases its 2019 annual report
GlobeNewswire 9/13/2019 Change of Chairman at ALK
GlobeNewswire 9/2/2019 Germany becomes first launch market for ALK’s tree SLIT-tablet
GlobeNewswire 8/28/2019 Allergy Immunotherapy Market is anticipated to clock a notable CAGR of over 10% through 2025 – Futur...
GlobeNewswire 8/13/2019 Six-month interim report (Q2) 2019
GlobeNewswire 8/12/2019 ALK upgrades its full-year financial outlook due to strong growth
GlobeNewswire 6/7/2019 ALK obtains European approval for its tree SLIT-tablet against allergic rhinitis
GlobeNewswire 5/9/2019 Three-month interim report (Q1) 2019
GlobeNewswire 4/5/2019 Ragweed Pollen Allergy Pipeline Review, H1 2019 - Therapeutics Analysis of 5 Companies & 6 Drug Prof...
GlobeNewswire 3/13/2019 Annual General Meeting in ALK-Abelló A/S held on 13 March 2019
GlobeNewswire 2/26/2019 New data shows ALK’s house dust mite SLIT-tablet significantly improves quality of sleep for allergi...
GlobeNewswire 2/14/2019 Annual General Meeting in ALK-Abelló A/S on 13 March 2019
GlobeNewswire 2/7/2019 ALK releases its annual report 2018
GlobeNewswire 1/15/2019 Large-scale paediatric SLIT-tablet trial meets primary endpoint, confirming potential in children
GlobeNewswire 12/18/2018 VIVO Announces Appointment of President, European Operations
GlobeNewswire 12/17/2018 Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...
GlobeNewswire 12/14/2018 ALK upgrades its full-year financial outlook due to accelerated sales
GlobeNewswire 8/22/2018 ALK submits registration application for tree SLIT-tablet in Europe
GlobeNewswire 8/15/2018 Six-month interim report (Q2) 2018
GlobeNewswire 6/13/2018 Results & Analysis from Nasdaq CRD Global Sustainability Index - Semi Annual Performance Review
GlobeNewswire 5/27/2018 Allergy experts: "Clinical effect of ALK’s tree SLIT-tablet among the most significant ever seen in ...
GlobeNewswire 5/4/2018 Three-month interim report (Q1) 2018
GlobeNewswire 4/27/2018 Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025, Says TMR
GlobeNewswire 4/17/2018 ALK’s partner for Japan, Torii, secures pricing for new Japanese cedar SLIT-tablet